These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22166440)

  • 1. Immunization strategies for Parkinson's disease.
    Ha D; Stone DK; Mosley RL; Gendelman HE
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S218-21. PubMed ID: 22166440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.
    Kosloski LM; Ha DM; Hutter JA; Stone DK; Pichler MR; Reynolds AD; Gendelman HE; Mosley RL
    J Neurochem; 2010 Sep; 114(5):1261-76. PubMed ID: 20524958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways towards an effective immunotherapy for Parkinson's disease.
    Hutter-Saunders JA; Mosley RL; Gendelman HE
    Expert Rev Neurother; 2011 Dec; 11(12):1703-15. PubMed ID: 22091596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
    Gendelman HE; Mosley RL
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.
    Machhi J; Kevadiya BD; Muhammad IK; Herskovitz J; Olson KE; Mosley RL; Gendelman HE
    Mol Neurodegener; 2020 Jun; 15(1):32. PubMed ID: 32503641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
    Harms AS; Ferreira SA; Romero-Ramos M
    Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.
    Olson KE; Gendelman HE
    Curr Opin Pharmacol; 2016 Feb; 26():87-95. PubMed ID: 26571205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T cells in the pathogenesis of Parkinson's disease.
    Chen Z; Chen S; Liu J
    Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?
    Romero-Ramos M; von Euler Chelpin M; Sanchez-Guajardo V
    Hum Vaccin Immunother; 2014; 10(4):852-67. PubMed ID: 24670306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease.
    Jiao Z; Zhang W; Chen C; Zhu X; Chen X; Zhou M; Peng G; Liu H; Qiu J; Lin Y; Huang S; Mo M; Yang X; Qu S; Xu P
    ACS Chem Neurosci; 2019 Feb; 10(2):803-811. PubMed ID: 30289236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination for Parkinson's disease.
    Schneeberger A; Mandler M; Mattner F; Schmidt W
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S11-3. PubMed ID: 22166404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immunity for the pathobiology of Parkinson's disease.
    Stone DK; Reynolds AD; Mosley RL; Gendelman HE
    Antioxid Redox Signal; 2009 Sep; 11(9):2151-66. PubMed ID: 19243239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization as treatment for Parkinson's disease.
    Agbo DB; Neff F; Seitz F; Binder C; Oertel WH; Bacher M; Dodel R
    J Neural Transm Suppl; 2009; (73):311-5. PubMed ID: 20411789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunization therapies for Parkinson's disease and multiple system atrophy.
    Schneeberger A; Tierney L; Mandler M
    Mov Disord; 2016 Feb; 31(2):214-24. PubMed ID: 26260853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.